AMO Pharma Limited Population Health Research Institute (PHRI) United Kingdom
07.08.2025 - 18:09:05AMO Pharma Announces Collaboration with Population Health Research Institute to Advance Proof of Concept Clinical Trial to Assess Efficacy of Tideglusib in Treatment of Arrhythmogenic Cardiomyopathy